Abstract
Allergic responses can be broadly divided into antibody-mediated and cell-mediated responses. This division was first appreciated by Zinsser (1925) who noted the delay in onset of skin reactions evoked in animals sensitized by intracellular parasites as compared with the relatively rapid response to antigen in animals sensitized by intradermal administration of protein antigen. An experimental basis for this distinction was provided by Landsteinder and Chase (1942), who demonstrated that delayed type hypersensitivity could be transferred to unsensitized guinea pigs by injection of live lymphoid cells from sensitized donor animals, but not by serum, dead cells or cell extracts. This contrasted with the immediate type of response which could be transferred to unsensitized animals by injection of serum and which was known to be attributable to immunoglobulins present in the serum. Subsequently, similar experimental evidence was obtained for other allergic responses of delayed onset, so that by the mid-1960s, there was general agreement as to the validity of grouping responses such as contact sensitivity, bacterial allergy and homograft rejection under the common heading of delayed hypersensitivity (Turk, 1967).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altman, L.C., Kirchner, H.: The production of a monocyte chemotactic factor by agammaglobulinemic chicken spleen cells. J. Immunol. 109, 1149–1151 (1972)
Altman, L.C., Snyderman, R., Oppenheim, J.J., Mergenhagen, S.E.: A human mononuclear leucocyte chemotactic factor: characterisation, specificity and kinetics of production by homologous leucocytes. J. Immunol. 110, 801–810 (1973)
Amos, H.E., Lachmann, P.J.: The immunological specificity of a macrophage inhibition factor. Immunology 18, 269–278 (1970)
Aronson, J.D.: Tissue culture studies on the relation of the tuberculin reaction to anaphylaxis and the Arthus phenomenon. J. Immunol. 25, 1 (1933)
Ashworth, L.A.E., Eckersley, B. J., Ford, W.H.: Comparison of the properties of two antigen-induced guinea-pig lymphokines. Int. Arch. Allergy 48, 143–155 (1975)
Askonase, P.W.: Cutaneous basophil hypersensitivity on contact-sensitised guinea-pigs. I. Transfer with immune serum. J. exp. Med. 138, 1144–1154 (1973)
Balow, J.E., Rosenthal, A.S.: Glucocorticoid suppression of macrophage migration inhibitory facto. J. exp. Med. 137, 1031–1041 (1973)
Bennett, B., Bloom, B.R.: Reactions in vivo and in vitro produced by a soluble substance associated with delayed type hypersensitivity. Proc. nat. Acad. Sci. (Wash.) 59, 756–782 (1968)
Black, J.W., Duncan, W.A.M., Durant, C.J., Ganellin, C.R., Parsons, E.M.: Definition and antagonism of histamine H2-receptors. Nature (Lond.) 236, 385–390 (1972)
Bloom, B.R.: In vitro approaches to the mechanism of cell-mediated immune reactions. Advanc. Immunol. 13, 101–208 (1971)
Bloom, B.R., Bennett, B.: Mechanisms of a reaction in vitro associated with delayed type hypersensitivity. Science 153, 80–82 (1966)
Bloom, B.R., Glade, P.R.: In vitro methods in cellular immunology. New York: Academic Press 1971
Boyden, S.: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. exp. Med. 115, 453–466 (1962)
Bray, M.A., Dumonde, D.C., Hanson, J.M., Morley, J., Wolstencroft, R.A., Smart, J.V.: Heterogeneity of guinea-pig lymphokines revealed by parallel bioassay. Clin. exp. Immunol. 23, 333–346 (1976 a)
Bray, M.A., Gordon, D.: Effects of anti-inflammatory drugs on macrophage prostaglandin biosynthesis. Brit. J. Pharmacol. 57, 466–467 P (1976)
Bray, M.A., Gordon, D., Morley, J.: Role of prostaglandins in reactions of cellular immunity. Brit. J. Pharmacol. 52, 453 P (1974)
Bray, M.A., Gordon, D., Morley, J.: Regulation of lymphokine secretion by prostaglandins. In: Velo, G.P., Giroud, J.P., Willoughby, D.A. (Eds.): Future Trends in Inflammation, Vol.II. Italy: Piccin Medical Books 1975
Bray, M.A., Gordon, D., Morley, J.: Regulation of lymphokine secretion by prostaglandins. Agents Actions 6, 171–175 (1976 b)
Caron, G.A.: The effects of concentration on antigen induced lymphocyte transformation in vitro. Int. Arch. Allergy 31, 441–448 (1967)
Caspary, E.A.: The mechanism of antigen induced electrophoretic mobility reduction of guineapig macrophages. Clin. exp. Immunol. 11, 305–309 (1972)
Cohen, S., Ward, P.A.: In vitro and in vivo activity of a lymphocyte and immune complex dependent chemotactic factor for eosinophils. J. exp. Med. 133, 133–145 (1971)
Coyne, J.A., Remold, H.G., Rosenberg, S.A., David, J.R.: Guinea-pig lymphotoxin (LT) IL Physicochemical properties of LT produced by lymphocytes stimulated with antigen or concanavallin A: its differentiation from migration inhibitory factor (MIF). J. Immunol. 110, 1630–637 (1973)
Crout, J.E., Hepburn, B., Ritts, R.E.: Suppression of lymphocyte transformation after aspirin injection. New Engl. J. Med. 292, 221–223 (1975)
Cuatracasas, P.: Membrane receptors. Ann. Rev. Biochem. 43, 169–214 (1974)
Dale, H.H.: Progress in autopharmacology: a survey of present knowledge of the chemical regulation of certain functions by natural constituents of the tissues. Bull. Johns Hopk. Hosp. 53, 297–347 (1933)
David, J.R.: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell antigen interaction. Proc. nat. Acad. Sci. (Wash.) 56, 72–77 (1966)
David, J.R.: Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J. exp. Med. 122, 1125–1134 (1965)
David, J.R., David, R.R.: Cellular hypersensitivity and immunity. Progr. Allergy 16, 300–449 (1972)
David, J.R., Lawrence, H.S., Thomas, L.: Delayed hypersensitivity in vitro. II. Effect of sensitive cells on normal cells in the presence of antigen. J. Immunol. 93, 274–278 (1964)
Dekaris, D., Smerdel, S., Veselic, B.: Inhibition of macrophage spreading by supernatants of antigen-stimulated sensitised lymphocytes. Europ. J. Immunol. 1, 402–404 (1971)
Dumonde, D.C., Howson, W. T., Wolstencroft, R.A.: The role of macrophages and lymphocytes in reactions of delayed hypersensitivity. In: Miescher, P.A., Graber, P. (Eds.): Vth Annual Symposium of Immunopathology, p.263. Basel: Schwabe 1968
Dumonde, D.C., Page, D.A., Matthew, M., Wolstencroft, R.A.: Role of lymphocyte activation products (LAP) in cell mediated immunity. I. Preparations and partial purification of guineapig LAP. Clin. exp. Immunol. 10, 25–47 (1972)
Dumonde, D.C., Wolstencroft, R.A., Panavi, G.S., Matthew, M., Morley, J., Howson, W.T.: Lymphognes: non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (Lond.) 224, 38–42 (1969)
Dvorak, A.M., Hammond, E., Dvorak, M.F., Karnovsky, M.J.: Loss of cell surface material from peritoneal exudate cells associated with lymphocyte mediated inhibition of macrophage migration from capillary tubes. Lab. Invest. 27, 561–574 (1972)
Dvorak, H.F.: Delayed hypersensitivity. In: Zweifach, B., McClusky, R.T., Grant, L. (Eds.): The Inflammatory Process, pp. 291–345. London: Academic Press 1974
Epstein, L.B., Cline, M.J., Menigan, T.C.: The interaction of human macrophages and lymphocytes in the phytohaemagglutinin stimulated production of interferon. J. clin. Invest. 50, 744–753 (1971)
Fauci, A.S., Dale, D.C.: The effect of in vivo hydrocortisone on sub-populations of human lymphocytes. J. clin. Invest. 53, 240–246 (1974)
Fisher, D.B., Mueller, G.C.: An early alteration in the phospholipid metabolism of lymphocytes by phytohaemagglutinin. Proc. nat. Acad. Sci. (Wash.) 60, 1396–1402 (1968)
Ford, W.H., Ashworth, L.A.E., Inder, S.: Effect of the concentrations of inducing agent on the output of lymphokines in the guineapig. Weinheim/Bergstr.: Verlag Chemie 1976. In press
Franco, M., Hanson, J.H., Morley, J., Wolstencroft, R.A.: Leucocyte chemotactic activity in the parallel bioassay of guinea-pig lymphokines. Clin. exp. Immunol. 32, 179–190 (1977)
Franco, M., Kelly, R.H., Morley, J.: Proceedings: a comparison of the haematogenous cell infiltrate produced by intradermal injection of lymphokine with that of delayed hypersensitivity. J. med. Microbiol. 8, Px-xi (1975)
Friedman, R.M., Cooper, H.L.: Stimulation of interferon production in human lymphocytes by mitogens. Proc. Soc. exp. Biol. (N.Y.) 125, 901–905 (1967)
Gell, P.G.H., Hinde, I. T.: Observations on the histology of the Arthus reaction and its relation to other known types of skin hypersensitivity. Int. Arch. Allergy 5, 23–46 (1954)
George, M., Vaughan, J.H.: In vitro cell migration as a model for delayed hypersensitivity. Proc. Soc. exp. Biol. (N.Y.) 111, 514–521 (1962)
Gordon, D., Bray, M.A., Morley, J.: Control of lymphokine secrection by prostaglandins. Nature (Lond.) 262, 401–402 (1976)
Granger, G.A.: In: Lawrence, H.S., Landy, M. (Eds.): Mediators of Cellular Immunity, pp.374–388. New York: Academic Press 1969
Green, J.A., Cooperbrand, J.S., Rutstein, J.A., Kibrick, S.: Immune specific induction of interferon production in cultures of human blood lymphocytes. Science 164, 1415–1417 (1969)
Green, J.A., Cooperbrand, S.R., Rutstein, J.A., Kibrick, S.: Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J. Immunol. 105, 48–54 (1970)
Hadden, J.W., Hadden, E.M., Haddox, M.K., Goldberg, N.D.: Guanosine 3′, 5′-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc. nat. Acad. Sci. (Wash.) 69, 3024–3027 (1972)
Hadden, J.W., Sadlik, J.R., Hadden, E.M.: Macrophage proliferation induced in vitro by a lymphocyte factor. Nature (Lond.) 257, 483–185 (1975)
Hitchens, M.: Molecular and cellular pharmacology of the anti-inflammatory drugs: some in vitro properties related to their possible modes of action. In: Scherrer, R.A., Whitehouse, M.W. (Eds.): Anti-inflammatory Agents: Chemistry and Pharmacology, Vol.II, pp.264–303. London: Academic Press 1974
Horton, J.E., Raisz, L.G., Simmons, H.A., Oppenheim, J.J., Mergenhagen, S.E.: Bone resorbing activity in supernatant fluid from cultured human peripheral blood leucocytes. Science 177, 793–795 (1972)
Janis, M., Bach, F.H.: Potentiation of in vitro lymphocyte reactivity. Nature (Lond.) 225, 238–239 (1970)
Jones, T.B., Mote, J.R.: The phases of foreign sensitisation in human beings. New Engl. J. Med. 210, 120–123 (1934)
Kasakura, S.: Heterogeneity of blastogenic factors produced in vitro by antigenically stimulated and unstimulated leucocytes. J. Immunol. 105, 1162–1167 (1970)
Kasakura, S., Lowenstein, L.: A factor stimulating DNA synthesis derived from the medium of leucocyte cultures. Nature (Lond.) 208, 794–795 (1965)
Kay, A.B.: Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin. exp. Immunol. 7, 723–727 (1970)
Keller, H.U., Sorkin, E.: Chemotaxis of leucocytes. Experientia (Basel) 24, 641–652 (1968)
Kelly, R.H., Wolstencroft, R.A.: Germinal centre proliferation in response to mitogenic lymphokine. Clin. exp. Immunol. 18, 321–336 (1974)
Kelly, R.H., Wolstencroft, R.A., Dumonde, D.C., Balfour, B. H.: Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin. exp. Immunol. 10, 49–65 (1972)
Kirby, P.J., Morley, J., Ponsford, J.R., McDonald, W.I.: Defective PGE reactivity in leucocytes of multiple sclerosis patients. Prostaglandins. (1976). In press
Kolb, W.P., Granger, G.A.: Lymphocyte in vitro cytotoxicity: characterisation of mouse lymphotoxin. Cell. Immunol. 1, 122–132 (1970)
Koopman, W.J., Gillis, M.H., David, J.R.: Prevention of MIF activity by agents known to increase cellular cylic AMP. J. Immunol. 110, 1609–1614 (1973)
Krejčí, J., Pekarek, J., Svejcar, J., Johanovsky, J.: Role of mediators of cellular hypersensitivity in the stimulation of the antibody response to an unrelated antigen. Cell. Immunol. 7, 323–327 (1973)
Landsteinder, K., Chase, M.W.: Experiments on transfer of cutaneous sensitivity to simple compounds. Proc. Soc. exp. Biol. (N.Y.) 49, 688–690 (1942)
Lebowitz, A.S., Lawrence, H.S.: The technique of clonal inhibition: a quantitative assay for human lymphotoxin activity. In: Bloom, B.R., Glade, P.R. (Eds.): In vitro Methods in Cell-Mediated Immunity, pp. 375–379. New York-London: Academic Press 1971
Lohmann-Matthes, M.-L., Ziegler, F.G., Fischer, H.: Macrophage cytotoxicity factor. A product of in vitro sensitised thymus dependant cells. Europ. J. Immunol. 3, 56–58 (1973)
Lolekha, S., Dray, S., Gotoff, S. P.: Macrophage aggregation in vitro—correlate of delayed hypersensitivity. J. Immunol. 104, 296–304 (1970)
Mackaness, G.B., Blanden, R.V.: Cellular immunity. Progr. Allergy 11, 89–140 (1967)
Maillard, J., Bloom, B.R.: Immunological adjuvants and the mechanism of cell co-operation. J. exp. Med. 136, 185–190 (1972)
Marks, J., James, D.M.: The effect of tuberculin on sensitised and normal leucocytes. J. Hyg. (Lond.) 51, 340–346 (1953)
Merigan, T.C.: In: Bloom, B.R., Glade, P. (Eds.): In vitro Methods in Cell-Mediated Immunity, pp. 81–89. New York: Academic Press 1971
Meyers, O.L., Shoji, M., Haber, E., Remold, H.G., David, J.R.: Cellular hypersensitivity: the production of antibody by cultures of lymphocytes producing migration inhibition factor. Cell. Immunol. 3, 442–447 (1972)
Morley, J.: Cell migration inhibition: an appraisal. Acta allerg. (Kbh.) 29, 185–208 (1974)
Morley, J.: The mode of action of aspirin. In: Dale, T.L.C. (Ed.): Proceedings of the Aspirin Symposium. London: Aspirin Foundation 1976a
Morley, J.: Prostaglandins as regulators of lymphoid cell function in allergic inflammation: a basis for chronicity in rheumatoid arthritis. In: Dumonde, D.C. (Ed.): Immunopathological Mechanisms in Relation to the Rheumatic Diseases, pp.511–517. Oxford: Blackwell 1976b
Morley, J., Bray, M.A., Gordon, D., Paul, W.: Interaction of prostaglandins and lymphokines in arthritis. In: Silvestri, L.G. (Ed.): The Immunological Basis of Connective Tissue Disorders, pp. 129–140. Amsterdam: North Holland Publishing Company 1975
Morley, J., Dumonde, D.C. Wolstencroft, R.A.: The measurement of lymphokines. In: Weir, D.M. (Ed.): Handbook of Experimental Immunology, Chap.28. Oxford: Blackwell 1973
Morley, J., Williams, T.J.: Increased vascular permeability in allergic inflammation. J. Physiol. (Lond.) 222, 95P–97P (1972 a)
Morley, J., Williams, T.J.: Inflammatory response produced by a factor released from lymphocytes. Brit. J. Pharmacol. 44, 384P (1972 b)
Morley, J., Williams, T.J.: Characterisation of delayed hypersensitivity by measurement of some local changes in vascular permeability: the place of the Jones-Mote reaction. In: Velo, G.P., Giroud, J.P., Willoughby, D.A. (Eds.): Future Trends in Inflammation, Vol. I, pp. 227–234. Italy: Piccin Medical Books 1973
Najarian J.S., Feldman, J.D.: Specificity of passively transferred delayed hypersensitivity. J. exp. Med. 118, 341–352 (1963)
Nathan, C.F., Karnovsky, M.L., David, J.R.: Alterations of macrophage functions by mediators from lymphocytes. J. exp. Med. 133, 1356–1376 (1971)
Nelson, D.S., Boyden, S. V.: The loss of macrophages from peritoneal exudates following the injection of antigens into guinea-pigs with delayed hypersensitivity. Immunology 6, 264–275 (1963)
Nowell, P.C.: Inhibition of human leucocyte mitosis by prednisolone in vitro. Cancer Res. 21, 1518–1521 (1961)
Outteridge, P.M., Lepper, A.W.D.: Immunosuppressive factors released by transforming lymphocytes in the delayed hypersensitivity skin response to tuberculin. Immunology 25, 981–994 (1973)
Pantalone, R.M., Page, R.C.: Lymphokine-induced production and release of lysosomal enzymes by macrophages. Proc. nat. Acad. Sci. (Wash.) 72, 2091–2094 (1975)
Papageorgiou, P.S., Henley, W.L., Glade, P. R.: Production and characterisation of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. J. Immunol. 108, 494–504 (1973)
Parker, C.W., Snyderman, D.E., Wedner, H.J.: The role of cyclic nucleotides in lymphocyte activation. In: Brent, L., Holborow, J. (Eds.): Progress in Immunology, Vol. II, pp. 85–94. Amsterdam: North Holland Publishing Company 1974a
Parker, C.W., Sullivan, T.J., Wedner, H.J.: In: Greengard, P., Robison, A.G. (Eds.): Advances in Cyclic Nucleotide Research, Vol. IV, p. 1. New York: Raven Press 1974b
Pekárek, J., Krejčí, J.: Survey of the methodological approaches to studying delayed hypersensitivity in vitro. J. immunol. Methods 6, 1–22 (1974)
Pick, E.: Soluble lymphocytic mediatorS. I. Inhibition of macrophage migration inhibitory factor production by drugs. Immunology 26, 649–658 (1974)
Pick, E., Krejci, J., Cech, K., Turk, J.L.: Interaction between ‘sensitised lymphocytes’ and antigen in vitro. I. The release of skin reactive factor. Immunology 17, 741–767 (1969)
Pick, E., Mannheim, S.: The mechanism of soluble lymphocytic mediators. II. Modification of macrophage migration and migration inhibitory aation by drugs, enzymes, and cationic environment. Cell. Immunol. 11, 30–46 (1974)
Pick, E., Turk, J.L.: Biological activities of soluble lymphocyte products. Clin. exp. Immunol. 10, 1–23 (1972)
Pogo, B.G.T., Allfrey, V.G., Mirsky, A.E.: RNA synthesis and histone acetylation during the course of gene activation in lymphocytes. Proc. nat. Acad. Sci. (Wash.) 55, 805–812 (1966)
Remold, H.G., Katz, A.B., Haber, E., David, J.R.: Studies on migration inhibitory factor (MIF): recovery of MIF activity, purification of gel filtration and disc electrophoresis. Cell. Immunol. 1, 133–145 (1970)
Remold, H.G., Ward, P., David, J.R.: Characterisation of migration inhibitory factor (MIF) and its separation from a chemotactic factor for monocytes. Int. Arch. Allergy 41, 15–17 (1971)
Remold-O’Donnell, E., Remold, H. G.: The enhancement of macrophage adenyl cyclase by products of activated lymphocytes. J. biol. Chem. 249, 3622–3627 (1974)
Rich, A.R., Lewis, M.R.: Nature of allergy in tuberculosis as revealed by tissue culture studies. Bull. Johns Hopk. Hosp. 50, 115–128 (1932)
Richerson, B.B., Dvorak, H.F., Leskowitz, S.: Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics. J. exp. Med. 132, 546–557 (1970)
Rocklin, R.E.: Products of activated lymphocytes: leucocyte inhibition factor (LIF) distinct from migration inhibition factor (MIF). J. Immunol. 112, 1461–1466 (1974)
Rocklin, R.E., MacDermott, R.P., Chess, L., Schlossman, S.E., David, J.R.: Studies on mediator production by highly purified human T and B lymphocytes. J. exp. Med. 140, 1303–1316 (1974)
Rocklin, R.E., Meyers, O.L., David, J.R.: An in vitro assay for cellular hypersensitivity in man. J. Immunol. 104, 95–102 (1970)
Salvin, S.B., Nishio, J., Gribik, M.: Lymphoid cells in delayed hypersensitivity. I. in vitro vs in vivo responses. Cell Immunol. 1, 62–77 (1970)
Schild, H.O., Willoughby, D.A.: Possible pharmacological mediators of delayed hypersensitivity. Brit. med. Bull. 23, 46–51 (1967)
Schwartz, H.J., Leon, M.A., Pelley, R.P.: Concanavallin A induced release of skin reactive factor from lymphoid cells. J. Immunol. 104, 265–268 (1970)
Smith, J.W., Steiner, A.L., Newberry, W.M., Parker, C.W.: Cyclic adenosine 3′,5′-monophosphate in human lymphocytes. Alterations after phytohaemagglutinin stimulation. J. clin. Invest. 50, 432–441 (1971a)
Smith, J.W., Steiner, A.L., Parker, C.W.: Human lymphocyte metabolism. Effects of cyclic and non-cyclic nucleotides on stimulation by phytohaemagglutinin. J. clin. Invest. 50, 442–448 (1971b)
Smith, R.T., Bauscher, J.A.C., Adler, W. H.: Studies of an inhibitor of DNA synthesis and a nonspecific mitogen elaborated by human lymphoblasts. Amer. J. Path. 60, 495–504 (1970)
Spitler, L., Benjamini, E., Young, J.D., Kaplan, H., Fudenberg, H.H.: Studies on the immune response to a characterised antigenic determinant of the tobacco mosaic virus protein. J. exp. Med. 131, 133–148 (1970)
Svejcar, J., Johanovsky, J., Pekárek, J.: Studies in the mechanism of delayed hypersensitivity in tissue cultures. XI. The influence of the substances released during the cultivation of lymph node cells from sensitised organism with antigen, on the migration activity of normal spleen cells. Z. Immun.-Forsch. 133, 259–274 (1967)
Turk, J.L. (Ed.): Delayed hypersensitivity: specific cell-mediated immunity. Brit. med. Bull. 23, 1–97 (1967)
Valentine, F.T., Lawrence, H.S.: Lymphocyte stimulation: transfer of cellular hypersensitivity to antigen in vitro. Science 165, 1014–1016 (1969)
Vane, J.R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol.) 231, 232–235 (1971)
Voisin, G.A., Toullet, F.: Modifications of capillary permeability in immunological reactions mediated through cells. In: Wolstenholme, G.E.W., O’Connor, M. (Eds.): Ciba Foundation Symposium on Cellular Aspects of Immunity, pp. 373–408. London: Churchill 1960
Wahl, S.M., Altman, L.C., Rosenstreich, D.L.: Inhibition of in vitro lymphokine synthesis by glucocorticosteroids. J. Immunol. 115, 476–481 (1975)
Ward, P.A., Remold, H.G., David, J.R.: Leucotactic factor produced by sensitised lymphocytes. Science 163, 1079–1081 (1969)
Ward, P.A., Remold, H.G., David, J.R.: The production by antigen-stimulated lymphocytes of a leucotactic factor distinct from migration inhibitory factor. Cell. Immunol. 1, 162–174 (1970)
Whitfield, J.F., Rixon, R.H., Mackmanus, J.P., Balk, S.D.: Calcium, cyclic adenosine 3′ 5′-mono-phosphate, and the control of cell proliferation: a review. In vitro 8, 257–278 (1973)
Williams, T.J.: Simultaneous measurement of local plasma exudation and blood flow changes induced by intradermal injection of vaso-active substances using 131I-albumin and 133Xe. J. Physiol. (Lond.) 254, 4–5 P (1976)
Williams, T.W., Granger, G.A.: Lymphocyte in vitro cytotoxicity. Mechanism of lymphotoxin-induced target cell distruction. J. Immunol. 102, 911–918 (1969)
Williams, T.J., Morley, J.: Measurement of the rate of extravasation of plasma protein in inflammatory responses in guinea-pig skin using a continuous recording method. Brit. J. exp. Path. 55, 1–12 (1974)
Willoughby, D.A., Boughton, B., Spector, W.G., Schild, H.O.: A vascular permeability factor extracted from normal and sensitized guinea-pig lymph node cells. Life Sci. 7, 347–352 (1962)
Wolstencroft, R.A., Dumonde, D.C.: In vitro studies of cell mediated immunity. I. Induction of lymphocyte transformation by a soluble ‘mitogenic’ factor derived from interaction of sensitised guinea-pig lymphoid cells with specific antigen. Immunology 18, 599–610 (1970)
Yoshida, T., Cohen, S., Bigazzi, P.E., Kurasuzi, T., Asmden, A.: Inflammatory mediators in culture filtrates of Escherichia coli. Macrophage migration inhibitory, neutrophil chemotactic, lymphocyte mitogenic and fibroblast cytotoxic activities. Amer. J. Path. 81, 389–400 (1975)
Yoshida, T., Janeway, C.A., Paul, W.E.: Activity of migration inhibitory factor in the absence of antigen. J. Immunol. 109, 201–206 (1972)
Zinsser, H.: Bacterial allergy and tissue reactions. Proc. Soc. exp. Biol. (N.Y.) 22, 35–39 (1925)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Morley, J. (1978). Lymphokines. In: Vane, J.R., Ferreira, S.H. (eds) Inflammation. Handbook of Experimental Pharmacology, vol 50 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66888-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-66888-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66890-6
Online ISBN: 978-3-642-66888-3
eBook Packages: Springer Book Archive